GE demonstrates 4D gating technology for radiotherapy planning

GE Healthcare exhibited its Advantage 4D gating technology used with multislice CT and PET/CT to analyze respiration-induced motion in the lung, breast and other cancers at the 46th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) this week in Atlanta.

Advantage 4D technology analyzes respiration motion using data acquired by the Varian Medical Systems' RPM (respiratory gating system) and imaging data acquired by GE's Discovery ST PET/CT scanner or Lightspeed RT wide-bore multislice CT scanner.

The imaging technology provides clinically relevant information on the true shape of anatomical objects in motion and identifies the precise range of motion, improving radiotherapy treatment planning, GE said.

The radiation therapy treatment planning tool automatically sorts image data into multiple phases of the respiratory cycle. The Advantage 4D review display then enables clinicians to view the anatomy in motion in real time. In addition, a contour visualization tool lets clinicians import contours and superimpose them over cine images in multiple planes. According to GE, this makes it easy to confirm the tumor motion and deformation relative to the planning target volume.

Early adopters of the technology include Massachusetts General Hospital in Boston and Texas Oncology Cancer Center in Austin.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup